BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4192759)

  • 21. Content of IgG, IgA and IgM immunoglobulins in international units in normal and IgA-enriched gammaglobulins.
    Hristova G; Bozadjiev L; Guturanov P; Peeva Z; Dimitrova Z
    Dev Biol Stand; 1974; 27():54-7. PubMed ID: 4142776
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative estimation of human immunoglobulins. I. Estimation of IGG, IGA and IGM immunoglobulins by the method of simple radial immunodiffusion.
    Skvaril F; Rádl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(1):107-17. PubMed ID: 4181518
    [No Abstract]   [Full Text] [Related]  

  • 25. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyrotoxicosis.
    Lancet; 1967 Dec; 2(7527):1186-7. PubMed ID: 4168385
    [No Abstract]   [Full Text] [Related]  

  • 27. [Histo-immunological detection of immunoglobulins IgG, IgM and IgA in serous papillary adenocarcinoma of the ovary].
    Montemagno U; Di Stefano M; Cardone A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(21):1356-8. PubMed ID: 4196113
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 29. [On LATS (long-acting thyroid stimulator)].
    Miyai K
    Nihon Byori Gakkai Kaishi; 1967; 56():Suppl:379-86. PubMed ID: 4181809
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
    Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
    [No Abstract]   [Full Text] [Related]  

  • 31. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophoretic and quantitative studies on serum proteins in thyroid diseases.
    Miklaszewska M; Checińska Z
    Mater Med Pol; 1973; 5(4):250-4. PubMed ID: 4133321
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 34. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of surgery and 131-I therapy for hyperthyroidism in the etiology of thyroid carcinoma.
    Ashkar FS; Miale A; Smoak WM; Weinstein MB
    South Med J; 1973 Sep; 66(9):1014-6. PubMed ID: 4733573
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioactive iodine therapy for progressive malignant exophthalmos.
    Bauer FK; Catz B
    Acta Endocrinol (Copenh); 1966 Jan; 51(1):14-22. PubMed ID: 5951904
    [No Abstract]   [Full Text] [Related]  

  • 37. Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis.
    Wyse EP; McConahey WM; Woolner LB; Scholz DA; Kearns TP
    J Clin Endocrinol Metab; 1968 Nov; 28(11):1623-9. PubMed ID: 5754841
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histoimmunological research on IgM, IgG and IgA immunoglobulines in post-molar choricoarcinoma].
    Montemagno U; Di Stefano M
    Boll Soc Ital Biol Sper; 1968 Feb; 44(3):167-9. PubMed ID: 4176913
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis.
    Hetzel BS; Mason EK; Wang HK
    Australas Ann Med; 1968 Nov; 17(4):307-11. PubMed ID: 4178378
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular autoimmune reactions following radioiodine treatment for hyperthyroidism.
    Einhorn N; Wasserman J; Packalén T
    Acta Radiol Ther Phys Biol; 1970 Jun; 9(3):225-32. PubMed ID: 4916356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.